This Viewpoint reviews the rationale for measuring health outcomes using quality-adjusted life-years (QALYs) and discusses the advantages and limitations of the measure and its role in attempts to define and promote the practice of high-value medicine.
No takes yet. Share an insight, caveat, or question.
Neumann et al. (2018) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: